{"id":789937,"date":"2023-10-12T10:23:29","date_gmt":"2023-10-12T14:23:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/"},"modified":"2023-10-12T10:23:29","modified_gmt":"2023-10-12T14:23:29","slug":"prophase-labs-to-present-at-the-thinkequity-conference-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/","title":{"rendered":"ProPhase Labs to Present at The ThinkEquity Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>GARDEN CITY, NY, Oct.  12, 2023  (GLOBE NEWSWIRE) &#8212; <\/strong>ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be participating in The ThinkEquity Conference, which will take place on October 19, 2023 at The Mandarin Oriental Hotel in New York.<\/p>\n<p align=\"justify\">ProPhase Labs\u2019 CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 11:30 AM ET on October 19th. Interested parties can register to attend\u00a0here:<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1QjEROoIr4cwhpgZ-AokXEeAlwjf57FaD6vuFhqmojcDvSAeA2OiPCQVr6Wd9P9sGBkI_6J2-3tEZUFSDfozXqhx9bv0jjsypLn3KsYvpfH-__nZt4xNROeGPMtlPexxNVXnsvlrtOD0nWXFXQ2a1hO4gTyzqsjxgN3jwFE5KN6ecYix8BaryCdAVdv4k9MkD9k6I4s3JsPrmVH5WtAy8Q==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.meetmax.com\/sched\/event_95483\/conference_register.html<\/a>\n      <\/p>\n<p align=\"justify\">One-on-one investor meetings will be held throughout the day.<\/p>\n<p align=\"justify\">The presentation will also be live-streamed at the following link:<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1QjEROoIr4cwhpgZ-AokXCNzYzJa_pRtks18-dMwZ_GT-enNzFOe2OivYVKWUPqv5bS2oXbD_THjmV5J4ofMCacQaSfRpHkATGrNTCKjlN8ABfeOOvCkfNpho6socLhR0ocQcfz04AxCJ8fIZ4zfBQ==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong>https:\/\/wsw.com\/webcast\/tep24\/prph\/1691270<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"justify\">\n        <strong>About\u00a0ProPhase\u00a0Labs<\/strong>\n      <\/p>\n<p align=\"justify\">ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d) is a next-generation biotech, genomics, therapeutics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We\u2019re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs\u2019 valuable subsidiaries, their synergies and significant growth underscore our multi-billion-dollar potential.<\/p>\n<p>For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7c7HCfddKD7Fw9TAu4bqttfBJpEaYe0IG7xvXltmMl2DOVrq2qu2fujwTavCl3VHMZEpfp7sGhehJEChjmhB9lPNrVEmoHRAValSVnrrVyQ=\" rel=\"nofollow noopener\" target=\"_blank\">www.ProPhaseLabs.com<\/a>.<\/p>\n<p>\n        <strong>Media Relations and Institutional\u00a0Investor Contact:<\/strong><br \/>\n        <br \/>ProPhase Labs, Inc.<br \/>267-880-1111<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MFUCwdjDjC_7G9MVcwFCj83GG1TR9QTMbNU69V09uGC3rfNCKCOVbLu-Rp1Lzgif7LzvJa5ZcXC6D4-9YAfSYhhF71qt-T650FHNCeYPK7X3ErS7gD7cNCd7yPCMijuR1s59ws8YyEAOskp7s53n5g==\" rel=\"nofollow noopener\" target=\"_blank\">investorrelations@prophaselabs.com<\/a><\/p>\n<p>\n        <strong>Retail Investor Relations Contact:<\/strong><br \/>\n        <br \/>Renmark Financial Communications<br \/>John Boidman<br \/>514-939-3989<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kroS3_MHsjQ2_JJ2Rcg0S_lYLPPxFXp9BWF3hTHic7YVeyH3F1eoJ1QwK7nq7Qo4IKiSRpwg1-bGTMn0bjA-aFamSi1K4Xyp7TcNMvPpodM217cq5cdJYsn8T3eo0iSd\" rel=\"nofollow noopener\" target=\"_blank\">Jboidman@renmarkfinancial.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YThiZDFmOGYtZGFiYS00NTMxLWJhNTktYzNlYjgzZmQ5ZTFjLTUwMDA0ODEyOQ==\/tiny\/ProPhase-Labs-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) &#8212; ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be participating in The ThinkEquity Conference, which will take place on October 19, 2023 at The Mandarin Oriental Hotel in New York. ProPhase Labs\u2019 CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 11:30 AM ET on October 19th. Interested parties can register to attend\u00a0here: https:\/\/www.meetmax.com\/sched\/event_95483\/conference_register.html One-on-one investor meetings will be held throughout the day. The presentation will also be live-streamed at the following link: https:\/\/wsw.com\/webcast\/tep24\/prph\/1691270 About\u00a0ProPhase\u00a0Labs ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d) is a next-generation biotech, genomics, therapeutics and diagnostics company. Our goal is to create a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProPhase Labs to Present at The ThinkEquity Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-789937","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProPhase Labs to Present at The ThinkEquity Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProPhase Labs to Present at The ThinkEquity Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) &#8212; ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be participating in The ThinkEquity Conference, which will take place on October 19, 2023 at The Mandarin Oriental Hotel in New York. ProPhase Labs\u2019 CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 11:30 AM ET on October 19th. Interested parties can register to attend\u00a0here: https:\/\/www.meetmax.com\/sched\/event_95483\/conference_register.html One-on-one investor meetings will be held throughout the day. The presentation will also be live-streamed at the following link: https:\/\/wsw.com\/webcast\/tep24\/prph\/1691270 About\u00a0ProPhase\u00a0Labs ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d) is a next-generation biotech, genomics, therapeutics and diagnostics company. Our goal is to create a &hellip; Continue reading &quot;ProPhase Labs to Present at The ThinkEquity Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-12T14:23:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProPhase Labs to Present at The ThinkEquity Conference\",\"datePublished\":\"2023-10-12T14:23:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/\",\"name\":\"ProPhase Labs to Present at The ThinkEquity Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==\",\"datePublished\":\"2023-10-12T14:23:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prophase-labs-to-present-at-the-thinkequity-conference-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProPhase Labs to Present at The ThinkEquity Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProPhase Labs to Present at The ThinkEquity Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/","og_locale":"en_US","og_type":"article","og_title":"ProPhase Labs to Present at The ThinkEquity Conference - Market Newsdesk","og_description":"GARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) &#8212; ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be participating in The ThinkEquity Conference, which will take place on October 19, 2023 at The Mandarin Oriental Hotel in New York. ProPhase Labs\u2019 CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 11:30 AM ET on October 19th. Interested parties can register to attend\u00a0here: https:\/\/www.meetmax.com\/sched\/event_95483\/conference_register.html One-on-one investor meetings will be held throughout the day. The presentation will also be live-streamed at the following link: https:\/\/wsw.com\/webcast\/tep24\/prph\/1691270 About\u00a0ProPhase\u00a0Labs ProPhase Labs, Inc. (Nasdaq: PRPH) (\u201cProPhase\u201d) is a next-generation biotech, genomics, therapeutics and diagnostics company. Our goal is to create a &hellip; Continue reading \"ProPhase Labs to Present at The ThinkEquity Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-12T14:23:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProPhase Labs to Present at The ThinkEquity Conference","datePublished":"2023-10-12T14:23:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/","name":"ProPhase Labs to Present at The ThinkEquity Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==","datePublished":"2023-10-12T14:23:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0Nzg4NyM1ODY4NjczIzUwMDA0ODEyOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prophase-labs-to-present-at-the-thinkequity-conference-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProPhase Labs to Present at The ThinkEquity Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=789937"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789937\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=789937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=789937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=789937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}